British Columbia Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.49M | Sell |
11,373
-2,477
| -18% | -$542K | 0.01% | 540 |
|
|
2025
Q1 | $3.1M | Sell |
13,850
-41
| -0.3% | -$9.18K | 0.02% | 519 |
|
|
2024
Q4 | $4.55M | Buy |
13,891
+1,736
| +14% | +$569K | 0.03% | 435 |
|
|
2024
Q3 | $3.65M | Sell |
12,155
-1,867
| -13% | -$560K | 0.02% | 449 |
|
|
2024
Q2 | $4.62M | Buy |
14,022
+5,188
| +59% | +$1.71M | 0.03% | 405 |
|
|
2024
Q1 | $3.5M | Sell |
8,834
-5,669
| -39% | -$2.24M | 0.02% | 413 |
|
|
2023
Q4 | $5.11M | Buy |
14,503
+1,755
| +14% | +$618K | 0.04% | 294 |
|
|
2023
Q3 | $4.78M | Buy |
12,748
+52
| +0.4% | +$19.5K | 0.05% | 262 |
|
|
2023
Q2 | $4.86M | Sell |
12,696
-8,396
| -40% | -$3.21M | 0.05% | 266 |
|
|
2023
Q1 | $7.31M | Sell |
21,092
-4,930
| -19% | -$1.71M | 0.08% | 215 |
|
|
2022
Q4 | $6.12M | Sell |
26,022
-762
| -3% | -$179K | 0.07% | 224 |
|
|
2022
Q3 | $6.59M | Sell |
26,784
-1,331
| -5% | -$328K | 0.07% | 227 |
|
|
2022
Q2 | $8.5M | Buy |
28,115
+10,679
| +61% | +$3.23M | 0.08% | 214 |
|
|
2022
Q1 | $7.16M | Sell |
17,436
-1,580
| -8% | -$649K | 0.05% | 311 |
|
|
2021
Q4 | $8.92M | Sell |
19,016
-11,625
| -38% | -$5.45M | 0.05% | 303 |
|
|
2021
Q3 | $13M | Sell |
30,641
-5,577
| -15% | -$2.37M | 0.08% | 230 |
|
|
2021
Q2 | $13M | Sell |
36,218
-3,896
| -10% | -$1.4M | 0.08% | 232 |
|
|
2021
Q1 | $11.3M | Sell |
40,114
-11,435
| -22% | -$3.22M | 0.08% | 226 |
|
|
2020
Q4 | $14.6M | Sell |
51,549
-12,116
| -19% | -$3.43M | 0.1% | 165 |
|
|
2020
Q3 | $17.5M | Sell |
63,665
-1,067
| -2% | -$293K | 0.14% | 122 |
|
|
2020
Q2 | $14.7M | Sell |
64,732
-3,165
| -5% | -$719K | 0.15% | 128 |
|
|
2020
Q1 | $10.3M | Buy |
67,897
+44,519
| +190% | +$6.78M | 0.18% | 108 |
|
|
2019
Q4 | $3.51M | Buy |
+23,378
| New | +$3.51M | 0.03% | 475 |
|